0001650840-23-000004.txt : 20231122 0001650840-23-000004.hdr.sgml : 20231122 20231122163734 ACCESSION NUMBER: 0001650840-23-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231122 DATE AS OF CHANGE: 20231122 EFFECTIVENESS DATE: 20231122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aerami Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001650840 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-498010 FILM NUMBER: 231433997 BUSINESS ADDRESS: STREET 1: 2520 MERIDIAN PARKWAY STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 9195897495 MAIL ADDRESS: STREET 1: 2520 MERIDIAN PARKWAY STREET 2: SUITE 400 CITY: DURHAM STATE: NC ZIP: 27713 FORMER COMPANY: FORMER CONFORMED NAME: Dance Biopharm Holdings, Inc. DATE OF NAME CHANGE: 20150819 FORMER COMPANY: FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc. DATE OF NAME CHANGE: 20150812 D 1 primary_doc.xml X0708 D LIVE 0001650840 Aerami Therapeutics Holdings, Inc. 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 919-797-9792 DELAWARE SAV Holdings Corp. Dance Biopharm Holdings, Inc. Dance BioPharm Holdings, Inc. Corporation true Anne C. Whitaker 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 Executive Officer Director Chief Executive Officer, Chairwoman of the Board Darlene Deptula-Hicks 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 Executive Officer Director Chief Financial Officer and Director Steven Thornton 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 Director Adam K. Stern 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 Director William Patrick Welch 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 Director John S. Patton 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 Director Joshua Ziel 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 Executive Officer Chief Operating Officer Gary C. Burgess 600 Park Offices Dr. Ste. 300 Durham NC NORTH CAROLINA 27709 Executive Officer Chief Medical Officer Other Health Care Decline to Disclose 06b false 2023-11-09 false true true false 0 Aegis Capital Corp. 15007 None None 1345 Avenue of Americas 27th Fl. New York NY NEW YORK 10105 AZ ARIZONA CA CALIFORNIA CO COLORADO FL FLORIDA IL ILLINOIS MD MARYLAND NV NEVADA NJ NEW JERSEY NY NEW YORK OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TN TENNESSEE TX TEXAS WV WEST VIRGINIA WI WISCONSIN true 20000000 1016000 18984000 The maximum offering amount is $10,000,000. If the offering is oversubscribed issuer and placement agent may at their mutual discretion have the issuer offer up to an additional $10,000,000 principal amount. The note offering will last until 1/3/2024. false 30 94000 0 The placement agent will also be issued warrants to purchase up to 10% of the number of shares of capital stock issuable upon the conversion of the Notes following the final closing of the note offering. 0 Proceeds to be used for general working capital as necessary, including strategic transaction opportunities, if any. A portion of proceeds will compensate the placement agent. Adam K. Stern, a director of issuer, is an affiliate of the placement agent. false Aerami Therapeutics Holdings, Inc. Darlene Deptula-Hicks Darlene Deptula-Hicks Chief Financial Officer 2023-11-22